1), the study population was divided as follows: the GLP-1RA cohort consisted of patients prescribed initial GLP-1RAs between April 2013 and April 2019 who were never prescribed SGLT2 inhibitors before the initial GLP-1RAs prescription, and the SGLT2 cohort consisted of patients prescribed initial SGLT2 inhibitors between April 2013 and April 2019 who were never prescribed GLP-1RAs before the initial SGLT2 prescription
GLP-1 Agonistic (Exenatide, Liraglutide) Insulin, Glucagon, Gastric emptying | Weight loss, Nausea 4
Individuals with this condition face substantially elevated risks of cardiovascular and chronic renal impairment, extrahepatic malignancies, and overall mortality [3-5]
Increasing glutathione levels has shown to improve vascular health, muscle strength, bone density, inflammation, immunity, cognitive function as well as delaying neurodegeneration
10.1016/j.bcp.2009.04.031 [DOI] [PubMed] [Google Scholar] Qu M., Jiang Z., Liao Y., Song Z., Nan X